Insiders at the Food and Drug Administration are ringing alarm bells over the agency's use of an AI to fast-track drug ...

Insiders tell CNN the FDA’s AI is “hallucinating” studies and can’t access key documents. Agency leaders insist the AI is ...

But three of those FDA employees told CNN that Elsa just makes up nonexistent studies, something commonly referred to in AI ...

The advent of artificial intelligence (AI) at the US Food and Drug Administration (FDA) is changing the complexion of the regulatory approval process for medical devices.

FDA officials say the assistant is flawed, just as the Trump administration stresses AI adoption in healthcare.

There’s no questioning that AI should have governance and guardrails. As much good as it can bring, it also heightens risk.

The federal agency introduced Elsa last month, boasting about the AI tool's ability to increase efficiency at the FDA.

The FDA's generative AI, Elsa, has a massive hallucination problem, according to the agency's employees themselves.

With reports that FDA’s AI Elsa is “confidently hallucinating” studies that don’t exist, the use of AI to streamline drug ...

"Elsa" is supposed to speed up the process of approving drugs and medical devices. But FDA employees say the AI is creating ...

Y ou'd have to be a special kind of Luddite to think that artificial intelligence won't change health care. The word ...

The administration's commissioner says scientists are using the AI for its organizational ability. Astronomer HR chief ...